CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection

Infection and Immunity

Volumn 81, Issue 10, 2013, Pages 3825-3834

  Kimura, Kazumi ^a   Kimura, Daisuke ^a   Matsushima, Yoshifumi ^a   Miyakoda, Mana ^a   Honma, Kiri ^a   Yuda, Masao ^b   Yuia, Katsuyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b MIE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOPLASM; LIVER CELL; LIVER PROTECTION; MOUSE; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM BERGHEI; PLASMODIUM MALARIAE INFECTION; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, PROTOZOAN; CD8-POSITIVE T-LYMPHOCYTES; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; LIVER; MALARIA; MICE; MICE, TRANSGENIC; NUCLEOPROTEINS; PLASMODIUM BERGHEI; PROTOZOAN PROTEINS;

EID: 84884390180     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00570-13     Document Type: Article

References (50)

1. Nussenzweig RS, Vanderberg J, Most H, Orton C. 1967. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature 216:160-162.
2. Hoffman SL, Doolan DL. 2000. Malaria vaccines-targeting infected hepatocytes. Nat. Med. 6:1218-1219.
3. Overstreet MG, Cockburn IA, Chen YC, Zavala F. 2008. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response. Immunol. Rev. 225:272-283.
4. Mueller AK, Labaied M, Kappe SH, Matuschewski K. 2005. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433:164-167.
5. Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT. 2011. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9:451-462.
6. Belnoue E, Voza T, Costa FT, Gruner AC, Mauduit M, Rosa DS, Depinay N, Kayibanda M, Vigario AM, Mazier D, Snounou G, Sinnis P, Renia L. 2008. Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J. Immunol. 181:8552-8558.
7. Doolan DL, Hoffman SL. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453-1462.
8. + T cells to sporozoite-induced protection against malaria. Immunology 80:1-5.
9. Good MF, Doolan DL. 2010. Malaria vaccine design: immunological considerations. Immunity 33:555-566.
10. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323-326.
11. Hafalla JC, Silvie O, Matuschewski K. 2011. Cell biology and immunology of malaria. Immunol. Rev. 240:297-316.
12. Kumar KA, Sano G, Boscardin S, Nussenzweig RS, Nussenzweig MC, Zavala F, Nussenzweig V. 2006. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444:937-940.
13. Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL. 1991. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 252:715-718.
14. Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, Gordon DM, Nussler AK, Aikawa M, Hoffman SL. 1992. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad. Sci. U. S. A. 89:9176-9180.
15. + T cell- and IFN-γ- dependent elimination of infected hepatocytes. J. Immunol. 157:4061-4067.
16. Weiss WR, Good MF, Hollingdale MR, Miller LH, Berzofsky JA. 1989. Genetic control of immunity to Plasmodium yoelii sporozoites. J. Immunol. 143:4263-4266.
17. Tarun AS, Peng X, Dumpit RF, Ogata Y, Silva-Rivera H, Camargo N, Daly TM, Bergman LW, Kappe SH. 2008. A combined transcriptome and proteome survey of malaria parasite liver stages. Proc. Natl. Acad. Sci. U. S. A. 105:305-310.
18. Speake C, Duffy PE. 2009. Antigens for pre-erythrocytic malaria vaccines: building on success. Parasite Immunol. 31:539-546.
19. Kaufmann SH, Hess J. 1999. Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development. Immunol. Lett. 65:81-84.
20. Mazzaccaro RJ, Gedde M, Jensen ER, van Santen HM, Ploegh HL, Rock KL, Bloom BR. 1996. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. U. S. A. 93:11786-11791.
21. Teitelbaum R, Cammer M, Maitland ML, Freitag NE, Condeelis J, Bloom BR. 1999. Mycobacterial infection of macrophages results in membrane-permeable phagosomes. Proc. Natl. Acad. Sci. U. S. A. 96: 15190-15195.
22. Garg N, Nunes MP, Tarleton RL. 1997. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol. 158:3293-3302.
23. Khan ZM, Ng C, Vanderberg JP. 1992. Early hepatic stages of Plasmodium berghei: release of circumsporozoite protein and host cellular inflammatory response. Infect. Immun. 60:264-270.
24. Hugel FU, Pradel G, Frevert U. 1996. Release of malaria circumsporozoite protein into the host cell cytoplasm and interaction with ribosomes. Mol. Biochem. Parasitol. 81:151-170.
25. + T cells in vitro. J. Immunol. 178: 7054-7063.
26. + T cells during blood stage of Plasmodium berghei infection. J. Immunol. 181:1420-1428.
27. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17-27.
28. Barnden MJ, Allison J, Heath WR, Carbone FR. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based - and-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34-40.
29. + T cells. Cell 71:1205-1214.
30. Kawabata Y, Udono H, Honma K, Ueda M, Mukae H, Kadota J, Kohno S, Yui K. 2002. Merozoite surface protein 1-specific immune response is protective against exoerythrocytic forms of Plasmodium yoelii. Infect. Immun. 70:6075-6082.
31. Ishino T, Yano K, Chinzei Y, Yuda M. 2004. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2:e4. doi:10.1371/journal.pbio.0020004.
32. + T-cell memory and prime-boost response after dendritic- cell vaccination. Nat. Med. 11:748-756.
33. + T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen. J. Immunol. 168:5737-5745.
34. Udono H, Yamano T, Kawabata Y, Ueda M, Yui K. 2001. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70. Int. Immunol. 13:1233-1242.
35. + T cell independent. J. Exp. Med. 191:403-408.
36. Gruring C, Heiber A, Kruse F, Ungefehr J, Gilberger TW, Spielmann T. 2011. Development and host cell modifications of Plasmodium falciparum blood stages in four dimensions. Nat. Commun. 2:165.
37. + T cells against malaria liver stages. J. Exp. Med. 194:173-180.
38. Rai D, Pham NL, Harty JT, Badovinac VP. 2009. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183:7672-7681.
39. Cockburn IA, Tse SW, Radtke AJ, Srinivasan P, Chen YC, Sinnis P, Zavala F. 2011. Dendritic cells and hepatocytes use distinct pathways to process protective antigen from plasmodium in vivo. PLoS Pathog. 7:e1001318. doi:10.1371/journal.ppat.1001318.
40. Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC, Gilbert SC, Hill AV, Bartholomay LC, Harty JT. 2008. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl. Acad. Sci. U. S. A. 105:14017-14022.
41. Sturm A, Amino R, van de Sand C, Regen T, RetzlaffS, Rennenberg A, Krueger A, Pollok JM, Menard R, Heussler VT. 2006. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313:1287-1290.
42. Amino R, Thiberge S, Martin B, Celli S, Shorte S, Frischknecht F, Menard R. 2006. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat. Med. 12:220-224.
43. Frevert U, Nardin E. 2008. Cellular effector mechanisms against Plasmodium liver stages. Cell. Microbiol. 10:1956-1967.
44. + T cell-mediated elimination of malaria liver stages. Proc. Natl. Acad. Sci. U. S. A. 110:9090-9095.
45. Renggli J, Hahne M, Matile H, Betschart B, Tschopp J, Corradin G. 1997. Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol. 19:145-148.
46. + T lymphocytes against liver stages of Plasmodium yoelii do not require β interferon for antiparasite activity. Infect. Immun. 76:3628-3631.
47. Butler NS, Schmidt NW, Harty JT. 2010. Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites. J. Immunol. 184:2528-2538.
48. + T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. J. Immunol. 183:5870-5878.
49. Trapani JA, Smyth MJ. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2:735-747.
50. Wohlleber D, Kashkar H, Gartner K, Frings MK, Odenthal M, Hegenbarth S, Borner C, Arnold B, Hammerling G, Nieswandt B, van Rooijen N, Limmer A, Cederbrant K, Heikenwalder M, Pasparakis M, Protzer U, Dienes HP, Kurts C, Kronke M, Knolle PA. 2012. TNF-induced target cell killing by CTL activated through cross-presentation. Cell Rep. 2:478-487